Our group recently identified a poor prognostic association between the HAPLN3 gene (Hyaluronan and Proteoglycan Link Protein 3) and a low NK cell infiltration in malignant melanoma patients, suggesting a potential inhibition of anti-tumor immune functions by HAPLN3 and identifying this gene as a potential target for immunotherapy (52). Here, HAPLN3 is linked to neoplasm.